STAR IDAZ Approach
Brucellosis is a significant zoonotic disease that affects livestock and humans globally. The STAR IDAZ International Research Consortium (IRC) is dedicated to addressing this challenge through a structured roadmap for vaccine development. This roadmap guides the research and development of effective and safe vaccines to prevent Brucellosis. By coordinating international efforts, STAR IDAZ aims to advance the creation of vaccines that can be widely implemented to control and eventually eradicate the disease, improving both animal and public health.
Working group
No Active Working Group for Brucellosis
N/A

Key People

Cynthia Baldwin,
University of Massachusetts (Amherst) United States

Clara Marín Alcalá,
Centro de Investigación y Tecnologia Agroalimentaria de Aragón Spain

Ruth Zadoks,
Sydney School of Veterinary Science Australia
Reports
Reports and outcomes from meetings and workshops
Research roadmaps
Gap analysis summary
The roadmap for the Brucella vaccine highlights several important areas that need to be focused on for the development of effective vaccine. These areas include the creation of vaccine that can distinguish between infected and vaccinated animals (DIVA), enhancing vaccine safety to prevent interference with diagnostic tests, and the creation of vaccines that offer sterile immunity. In addition, there is a need for a better understanding of the interactions between Brucella and the host, identification of protective antigens, and overcoming technological challenges in vaccine delivery systems. Addressing these gaps is crucial in advancing the development of safe and effective Brucella vaccines.
Projects
Displaying 4 of 28 projects
VIEW ALL PROJECTSEVOZOOM – Evolution and Zoonotic Epidemiology of Bovine Tuberculosis
Planned Completion date
United Kingdom
Milk proteins in bovine mastitis: biomarkers of disease and biological function
Planned Completion date
United Kingdom
Investigating mechanisms of gallbladder persistence in Salmonella
Planned Completion date
United Kingdom
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
Planned Completion date 01/12/2025
United Kingdom